These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients. Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169 [TBL] [Abstract][Full Text] [Related]
26. Tardive dyskinesia and plasma homovanillic acid. Moore DC; Glazer WM; Bowers MB; Heninger GR Biol Psychiatry; 1983 Dec; 18(12):1393-402. PubMed ID: 6140961 [TBL] [Abstract][Full Text] [Related]
27. Serum interferon in schizophrenia. Rimón R; Ahokas A; Hintikka J; Heikkilä L Ann Clin Res; 1985; 17(4):139-40. PubMed ID: 4073801 [TBL] [Abstract][Full Text] [Related]
28. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia. Segman RH; Heresco-Levy U; Finkel B; Goltser T; Shalem R; Schlafman M; Dorevitch A; Yakir A; Greenberg D; Lerner A; Lerer B Mol Psychiatry; 2001 Mar; 6(2):225-9. PubMed ID: 11317227 [TBL] [Abstract][Full Text] [Related]
29. No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients. Kang SG; Choi JE; An H; Lim SW; Lee HJ; Han C; Kim YK; Kim SH; Cho SN; Lee MS; Joe SH; Jung IK; Kim L Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1545-8. PubMed ID: 18602732 [TBL] [Abstract][Full Text] [Related]
30. Tardive dyskinesia in outpatient schizophrenics treated with depot phenothiazines. Williams R; Naya A; Dalby JT J Clin Psychopharmacol; 1986 Oct; 6(5):318-9. PubMed ID: 3771819 [No Abstract] [Full Text] [Related]
31. Prolactin response to sodium valproate in schizophrenics with and without tardive dyskinesia. Monteleone P; Maj M; Ariano MG; Iovino M; Fiorenza L; Steardo L Psychopharmacology (Berl); 1988; 96(2):223-6. PubMed ID: 3148149 [TBL] [Abstract][Full Text] [Related]
32. Serum vitamin B6 in schizophrenic and schizoaffective patients with and without tardive dyskinesia. Miodownik C; Lerner V; Cohen H; Kotler M Clin Neuropharmacol; 2000; 23(4):212-5. PubMed ID: 11020126 [TBL] [Abstract][Full Text] [Related]
33. Relationship of butaperazine blood levels to plasma prolactin in chronic schizophrenic patients. Smith RC; Tamminga CA; Crayton JW; Dekirmenjian H; Davis JM Psychopharmacology (Berl); 1979; 66(1):29-33. PubMed ID: 44374 [TBL] [Abstract][Full Text] [Related]
34. The plasma phenylalanine/large neutral amino acid ratio: a risk factor for tardive dyskinesia. Richardson MA; Suckow R; Whittaker R; Boggiano W; Sziraki I; Kushner H; Perumal A Psychopharmacol Bull; 1989; 25(1):47-51. PubMed ID: 2772116 [No Abstract] [Full Text] [Related]